Evid Invest
Who owns BCRXWhat BCRX owns — n/a

Who owns BIOCRYST PHARMACEUTICALS INC?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of BCRX from SEC Form 13F filings across 334 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 334 institutions disclosed 243.8M shares of BIOCRYST PHARMACEUTICALS INC worth $2.03B — about 95.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

334

13F holders

$2.03B

value, 2026 filers

95.4%

of shares outstanding (243.8M sh)

54

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BCRX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.24.3M$202.7M0.0%9.5%+1.8%
2DEERFIELD MANAGEMENT COMPANY, L.P.15.5M$129.0M2.0%6.1%+2.6%
3STATE STREET CORP12.3M$102.4M0.0%4.8%-19.1%
4VANGUARD CAPITAL MANAGEMENT LLC11.3M$93.9M0.0%4.4%-0.9%
5TCG Crossover Management, LLC11.0M$91.8M2.6%4.3%0.0%
6VANGUARD PORTFOLIO MANAGEMENT LLC10.5M$87.7M0.0%4.1%-5.4%
7PERCEPTIVE ADVISORS LLC10.3M$85.8M1.5%4%-0.1%
8Janus Henderson Group Ltd.NEW10.3M$85.3M0.0%4%new
9TWO SIGMA INVESTMENTS, LP7.2M$60.0M0.0%2.8%+6.3%
10Jones Hill Capital LPNEW7.1M$59.0M10.0%2.8%new
11Aberdeen Group plc6.5M$53.9M0.1%2.5%+21.8%
12GEODE CAPITAL MANAGEMENT, LLC6.1M$50.4M0.0%2.4%-3.2%
13BANK OF AMERICA CORP /DE/5.4M$45.2M0.0%2.1%+13.1%
14UBS Group AG5.4M$44.9M0.0%2.1%+6.0%
15GOLDMAN SACHS GROUP INC4.2M$35.3M0.0%1.7%-5.5%
16Nuveen, LLC4.0M$33.7M0.0%1.6%+0.9%
17Frazier Life Sciences Management, L.P.4.0M$33.4M0.8%1.6%0.0%
18JUPITER ASSET MANAGEMENT LTD4.0M$33.3M0.2%1.6%+143.2%
19MORGAN STANLEY3.5M$28.7M0.0%1.3%+72.5%
20GW&K Investment Management, LLC3.4M$28.0M0.2%1.3%+6.0%
21HRT FINANCIAL LP2.7M$22.5M0.0%1.1%+149.6%
22Kynam Capital Management, LP2.5M$21.0M1.2%1%0.0%
23Candriam S.C.A.2.5M$21.0M0.1%1%0.0%
24Fisher Asset Management, LLC2.4M$20.4M0.0%1%-6.0%
25CHARLES SCHWAB INVESTMENT MANAGEMENT INC2.3M$19.1M0.0%0.9%-2.4%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.